カテゴリー： 世界, 医療/バイオ, LP Information

世界のかゆみ止め薬市場予測 2023年-2029年

【英語タイトル】Global Anti-itch Drugs Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00448）・商品コード：LP23DC00448
・発行会社（調査会社）：LP Information
・発行日：2023年11月（※2025年版があります。お問い合わせください。）
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥519,720見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥779,580見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,039,440見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のかゆみ止め薬市場」は、過去の販売実績から2022年の世界のかゆみ止め薬の総販売量を検討し、2023年から2029年の予測されるかゆみ止め薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のかゆみ止め薬の市場規模を掲載し、XXX百万米ドル規模の世界のかゆみ止め薬市場の詳細な分析を提供します。本インサイトレポートは、世界のかゆみ止め薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のかゆみ止め薬市場における各社の独自のポジションをより深く理解するために、かゆみ止め薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のかゆみ止め薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。かゆみ止め薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。かゆみ止め薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。かゆみ止め薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

かゆみ止め薬の世界主要メーカーとしては、Johnson & Johnson、 Bayer、 Sanofi、 Combe Incorporated、 CR SANJIU、 Lingrui、 Jinyao Pharma、 Dinuo Pharma、 Huapont、 Medimetriks Pharmaceuticals、 Taro Pharmaceutical、 Teva、 Sun Pharmaceutical、 Perrigoなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のかゆみ止め薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではかゆみ止め薬市場をセグメンテーションし、種類別 (単一製剤、複合軟膏)、用途別 (病院、薬局、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：単一製剤、複合軟膏

・用途別区分：病院、薬局、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のかゆみ止め薬市場の10年間の市場状況・展望は？
・世界および地域別に見たかゆみ止め薬市場成長の要因は何か？
・かゆみ止め薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・かゆみ止め薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：かゆみ止め薬の年間販売量2018-2029、地域別現状・将来分析
・かゆみ止め薬の種類別セグメント：単一製剤、複合軟膏
・かゆみ止め薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・かゆみ止め薬の用途別セグメント：病院、薬局、その他
・かゆみ止め薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のかゆみ止め薬市場
・企業別のグローバルかゆみ止め薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別のかゆみ止め薬の年間売上：2018-2023年の売上、市場シェア
・企業別のかゆみ止め薬販売価格
・主要企業のかゆみ止め薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

かゆみ止め薬の地域別レビュー
・地域別のかゆみ止め薬市場規模2018-2023：年間販売量、売上
・主要国別のかゆみ止め薬市場規模2018-2023：年間販売量、売上
・南北アメリカのかゆみ止め薬販売の成長
・アジア太平洋のかゆみ止め薬販売の成長
・ヨーロッパのかゆみ止め薬販売の成長
・中東・アフリカのかゆみ止め薬販売の成長

南北アメリカ市場
・南北アメリカの国別のかゆみ止め薬販売量、売上（2018-2023）
・南北アメリカのかゆみ止め薬の種類別販売量
・南北アメリカのかゆみ止め薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のかゆみ止め薬販売量、売上（2018-2023）
・アジア太平洋のかゆみ止め薬の種類別販売量
・アジア太平洋のかゆみ止め薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のかゆみ止め薬販売量、売上（2018-2023）
・ヨーロッパのかゆみ止め薬の種類別販売量
・ヨーロッパのかゆみ止め薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のかゆみ止め薬販売量、売上（2018-2023）
・中東・アフリカのかゆみ止め薬の種類別販売量
・中東・アフリカのかゆみ止め薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・かゆみ止め薬の製造コスト構造分析
・かゆみ止め薬の製造プロセス分析
・かゆみ止め薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・かゆみ止め薬の主要なグローバル販売業者
・かゆみ止め薬の主要なグローバル顧客

地域別のかゆみ止め薬市場予測レビュー
・地域別のかゆみ止め薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・かゆみ止め薬の種類別市場規模予測
・かゆみ止め薬の用途別市場規模予測

主要企業分析
Johnson & Johnson、 Bayer、 Sanofi、 Combe Incorporated、 CR SANJIU、 Lingrui、 Jinyao Pharma、 Dinuo Pharma、 Huapont、 Medimetriks Pharmaceuticals、 Taro Pharmaceutical、 Teva、 Sun Pharmaceutical、 Perrigo
・企業情報
・かゆみ止め薬製品
・かゆみ止め薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Anti-itch Drugs market size is projected to grow from US$ 3296.7 million in 2022 to US$ 4568.7 million in 2029; it is expected to grow at a CAGR of 4.8% from 2023 to 2029.
The market for anti-itch ointments is expected to grow steadily in the coming years due to several factors. First, the incidence of skin conditions that cause itchiness is increasing worldwide, largely due to environmental factors such as pollution and climate change. Additionally, an aging population is expected to drive demand for anti-itch ointments, as older adults are more likely to develop skin conditions that cause itchiness.
An antipruritic ointment is a topical medication used to relieve itching (pruritus) of the skin. It works by reducing the sensation of itching and soothing the skin.
LPI (LP Information)’ newest research report, the “Anti-itch Drugs Industry Forecast” looks at past sales and reviews total world Anti-itch Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-itch Drugs sales for 2023 through 2029. With Anti-itch Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-itch Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-itch Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-itch Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-itch Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-itch Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-itch Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-itch Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Single Preparation
Compound Ointment
Segmentation by application
Hospital
Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Johnson & Johnson
Bayer
Sanofi
Combe Incorporated
CR SANJIU
Lingrui
Jinyao Pharma
Dinuo Pharma
Huapont
Medimetriks Pharmaceuticals
Taro Pharmaceutical
Teva
Sun Pharmaceutical
Perrigo
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anti-itch Drugs market?
What factors are driving Anti-itch Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-itch Drugs market opportunities vary by end market size?
How does Anti-itch Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-itch Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anti-itch Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anti-itch Drugs by Country/Region, 2018, 2022 & 2029
2.2 Anti-itch Drugs Segment by Type
2.2.1 Single Preparation
2.2.2 Compound Ointment
2.3 Anti-itch Drugs Sales by Type
2.3.1 Global Anti-itch Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Anti-itch Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anti-itch Drugs Sale Price by Type (2018-2023)
2.4 Anti-itch Drugs Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Other
2.5 Anti-itch Drugs Sales by Application
2.5.1 Global Anti-itch Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Anti-itch Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anti-itch Drugs Sale Price by Application (2018-2023)
3 Global Anti-itch Drugs by Company
3.1 Global Anti-itch Drugs Breakdown Data by Company
3.1.1 Global Anti-itch Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Anti-itch Drugs Sales Market Share by Company (2018-2023)
3.2 Global Anti-itch Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Anti-itch Drugs Revenue by Company (2018-2023)
3.2.2 Global Anti-itch Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Anti-itch Drugs Sale Price by Company
3.4 Key Manufacturers Anti-itch Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-itch Drugs Product Location Distribution
3.4.2 Players Anti-itch Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-itch Drugs by Geographic Region
4.1 World Historic Anti-itch Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Anti-itch Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anti-itch Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anti-itch Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Anti-itch Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anti-itch Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anti-itch Drugs Sales Growth
4.4 APAC Anti-itch Drugs Sales Growth
4.5 Europe Anti-itch Drugs Sales Growth
4.6 Middle East & Africa Anti-itch Drugs Sales Growth
5 Americas
5.1 Americas Anti-itch Drugs Sales by Country
5.1.1 Americas Anti-itch Drugs Sales by Country (2018-2023)
5.1.2 Americas Anti-itch Drugs Revenue by Country (2018-2023)
5.2 Americas Anti-itch Drugs Sales by Type
5.3 Americas Anti-itch Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-itch Drugs Sales by Region
6.1.1 APAC Anti-itch Drugs Sales by Region (2018-2023)
6.1.2 APAC Anti-itch Drugs Revenue by Region (2018-2023)
6.2 APAC Anti-itch Drugs Sales by Type
6.3 APAC Anti-itch Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-itch Drugs by Country
7.1.1 Europe Anti-itch Drugs Sales by Country (2018-2023)
7.1.2 Europe Anti-itch Drugs Revenue by Country (2018-2023)
7.2 Europe Anti-itch Drugs Sales by Type
7.3 Europe Anti-itch Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-itch Drugs by Country
8.1.1 Middle East & Africa Anti-itch Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anti-itch Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Anti-itch Drugs Sales by Type
8.3 Middle East & Africa Anti-itch Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-itch Drugs
10.3 Manufacturing Process Analysis of Anti-itch Drugs
10.4 Industry Chain Structure of Anti-itch Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-itch Drugs Distributors
11.3 Anti-itch Drugs Customer
12 World Forecast Review for Anti-itch Drugs by Geographic Region
12.1 Global Anti-itch Drugs Market Size Forecast by Region
12.1.1 Global Anti-itch Drugs Forecast by Region (2024-2029)
12.1.2 Global Anti-itch Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-itch Drugs Forecast by Type
12.7 Global Anti-itch Drugs Forecast by Application
13 Key Players Analysis
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Anti-itch Drugs Product Portfolios and Specifications
13.1.3 Johnson & Johnson Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Anti-itch Drugs Product Portfolios and Specifications
13.2.3 Bayer Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Anti-itch Drugs Product Portfolios and Specifications
13.3.3 Sanofi Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Combe Incorporated
13.4.1 Combe Incorporated Company Information
13.4.2 Combe Incorporated Anti-itch Drugs Product Portfolios and Specifications
13.4.3 Combe Incorporated Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Combe Incorporated Main Business Overview
13.4.5 Combe Incorporated Latest Developments
13.5 CR SANJIU
13.5.1 CR SANJIU Company Information
13.5.2 CR SANJIU Anti-itch Drugs Product Portfolios and Specifications
13.5.3 CR SANJIU Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CR SANJIU Main Business Overview
13.5.5 CR SANJIU Latest Developments
13.6 Lingrui
13.6.1 Lingrui Company Information
13.6.2 Lingrui Anti-itch Drugs Product Portfolios and Specifications
13.6.3 Lingrui Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Lingrui Main Business Overview
13.6.5 Lingrui Latest Developments
13.7 Jinyao Pharma
13.7.1 Jinyao Pharma Company Information
13.7.2 Jinyao Pharma Anti-itch Drugs Product Portfolios and Specifications
13.7.3 Jinyao Pharma Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Jinyao Pharma Main Business Overview
13.7.5 Jinyao Pharma Latest Developments
13.8 Dinuo Pharma
13.8.1 Dinuo Pharma Company Information
13.8.2 Dinuo Pharma Anti-itch Drugs Product Portfolios and Specifications
13.8.3 Dinuo Pharma Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Dinuo Pharma Main Business Overview
13.8.5 Dinuo Pharma Latest Developments
13.9 Huapont
13.9.1 Huapont Company Information
13.9.2 Huapont Anti-itch Drugs Product Portfolios and Specifications
13.9.3 Huapont Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Huapont Main Business Overview
13.9.5 Huapont Latest Developments
13.10 Medimetriks Pharmaceuticals
13.10.1 Medimetriks Pharmaceuticals Company Information
13.10.2 Medimetriks Pharmaceuticals Anti-itch Drugs Product Portfolios and Specifications
13.10.3 Medimetriks Pharmaceuticals Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Medimetriks Pharmaceuticals Main Business Overview
13.10.5 Medimetriks Pharmaceuticals Latest Developments
13.11 Taro Pharmaceutical
13.11.1 Taro Pharmaceutical Company Information
13.11.2 Taro Pharmaceutical Anti-itch Drugs Product Portfolios and Specifications
13.11.3 Taro Pharmaceutical Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Taro Pharmaceutical Main Business Overview
13.11.5 Taro Pharmaceutical Latest Developments
13.12 Teva
13.12.1 Teva Company Information
13.12.2 Teva Anti-itch Drugs Product Portfolios and Specifications
13.12.3 Teva Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Teva Main Business Overview
13.12.5 Teva Latest Developments
13.13 Sun Pharmaceutical
13.13.1 Sun Pharmaceutical Company Information
13.13.2 Sun Pharmaceutical Anti-itch Drugs Product Portfolios and Specifications
13.13.3 Sun Pharmaceutical Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Sun Pharmaceutical Main Business Overview
13.13.5 Sun Pharmaceutical Latest Developments
13.14 Perrigo
13.14.1 Perrigo Company Information
13.14.2 Perrigo Anti-itch Drugs Product Portfolios and Specifications
13.14.3 Perrigo Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Perrigo Main Business Overview
13.14.5 Perrigo Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Anti-itch Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Anti-itch Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Single Preparation
Table 4. Major Players of Compound Ointment
Table 5. Global Anti-itch Drugs Sales by Type (2018-2023) & (K Units)
Table 6. Global Anti-itch Drugs Sales Market Share by Type (2018-2023)
Table 7. Global Anti-itch Drugs Revenue by Type (2018-2023) & ($ million)
Table 8. Global Anti-itch Drugs Revenue Market Share by Type (2018-2023)
Table 9. Global Anti-itch Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Anti-itch Drugs Sales by Application (2018-2023) & (K Units)
Table 11. Global Anti-itch Drugs Sales Market Share by Application (2018-2023)
Table 12. Global Anti-itch Drugs Revenue by Application (2018-2023)
Table 13. Global Anti-itch Drugs Revenue Market Share by Application (2018-2023)
Table 14. Global Anti-itch Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Anti-itch Drugs Sales by Company (2018-2023) & (K Units)
Table 16. Global Anti-itch Drugs Sales Market Share by Company (2018-2023)
Table 17. Global Anti-itch Drugs Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Anti-itch Drugs Revenue Market Share by Company (2018-2023)
Table 19. Global Anti-itch Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Anti-itch Drugs Producing Area Distribution and Sales Area
Table 21. Players Anti-itch Drugs Products Offered
Table 22. Anti-itch Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Anti-itch Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Anti-itch Drugs Sales Market Share Geographic Region (2018-2023)
Table 27. Global Anti-itch Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Anti-itch Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Anti-itch Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Anti-itch Drugs Sales Market Share by Country/Region (2018-2023)
Table 31. Global Anti-itch Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Anti-itch Drugs Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Anti-itch Drugs Sales by Country (2018-2023) & (K Units)
Table 34. Americas Anti-itch Drugs Sales Market Share by Country (2018-2023)
Table 35. Americas Anti-itch Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Anti-itch Drugs Revenue Market Share by Country (2018-2023)
Table 37. Americas Anti-itch Drugs Sales by Type (2018-2023) & (K Units)
Table 38. Americas Anti-itch Drugs Sales by Application (2018-2023) & (K Units)
Table 39. APAC Anti-itch Drugs Sales by Region (2018-2023) & (K Units)
Table 40. APAC Anti-itch Drugs Sales Market Share by Region (2018-2023)
Table 41. APAC Anti-itch Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Anti-itch Drugs Revenue Market Share by Region (2018-2023)
Table 43. APAC Anti-itch Drugs Sales by Type (2018-2023) & (K Units)
Table 44. APAC Anti-itch Drugs Sales by Application (2018-2023) & (K Units)
Table 45. Europe Anti-itch Drugs Sales by Country (2018-2023) & (K Units)
Table 46. Europe Anti-itch Drugs Sales Market Share by Country (2018-2023)
Table 47. Europe Anti-itch Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Anti-itch Drugs Revenue Market Share by Country (2018-2023)
Table 49. Europe Anti-itch Drugs Sales by Type (2018-2023) & (K Units)
Table 50. Europe Anti-itch Drugs Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Anti-itch Drugs Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Anti-itch Drugs Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Anti-itch Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Anti-itch Drugs Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Anti-itch Drugs Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Anti-itch Drugs Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Anti-itch Drugs
Table 58. Key Market Challenges & Risks of Anti-itch Drugs
Table 59. Key Industry Trends of Anti-itch Drugs
Table 60. Anti-itch Drugs Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Anti-itch Drugs Distributors List
Table 63. Anti-itch Drugs Customer List
Table 64. Global Anti-itch Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Anti-itch Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Anti-itch Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Anti-itch Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Anti-itch Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Anti-itch Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Anti-itch Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Anti-itch Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Anti-itch Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Anti-itch Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Anti-itch Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Anti-itch Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Anti-itch Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Anti-itch Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Johnson & Johnson Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Johnson & Johnson Anti-itch Drugs Product Portfolios and Specifications
Table 80. Johnson & Johnson Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Johnson & Johnson Main Business
Table 82. Johnson & Johnson Latest Developments
Table 83. Bayer Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Anti-itch Drugs Product Portfolios and Specifications
Table 85. Bayer Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Bayer Main Business
Table 87. Bayer Latest Developments
Table 88. Sanofi Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Anti-itch Drugs Product Portfolios and Specifications
Table 90. Sanofi Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Combe Incorporated Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Combe Incorporated Anti-itch Drugs Product Portfolios and Specifications
Table 95. Combe Incorporated Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Combe Incorporated Main Business
Table 97. Combe Incorporated Latest Developments
Table 98. CR SANJIU Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. CR SANJIU Anti-itch Drugs Product Portfolios and Specifications
Table 100. CR SANJIU Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. CR SANJIU Main Business
Table 102. CR SANJIU Latest Developments
Table 103. Lingrui Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Lingrui Anti-itch Drugs Product Portfolios and Specifications
Table 105. Lingrui Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Lingrui Main Business
Table 107. Lingrui Latest Developments
Table 108. Jinyao Pharma Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Jinyao Pharma Anti-itch Drugs Product Portfolios and Specifications
Table 110. Jinyao Pharma Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Jinyao Pharma Main Business
Table 112. Jinyao Pharma Latest Developments
Table 113. Dinuo Pharma Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Dinuo Pharma Anti-itch Drugs Product Portfolios and Specifications
Table 115. Dinuo Pharma Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Dinuo Pharma Main Business
Table 117. Dinuo Pharma Latest Developments
Table 118. Huapont Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Huapont Anti-itch Drugs Product Portfolios and Specifications
Table 120. Huapont Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Huapont Main Business
Table 122. Huapont Latest Developments
Table 123. Medimetriks Pharmaceuticals Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Medimetriks Pharmaceuticals Anti-itch Drugs Product Portfolios and Specifications
Table 125. Medimetriks Pharmaceuticals Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Medimetriks Pharmaceuticals Main Business
Table 127. Medimetriks Pharmaceuticals Latest Developments
Table 128. Taro Pharmaceutical Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Taro Pharmaceutical Anti-itch Drugs Product Portfolios and Specifications
Table 130. Taro Pharmaceutical Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Taro Pharmaceutical Main Business
Table 132. Taro Pharmaceutical Latest Developments
Table 133. Teva Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Teva Anti-itch Drugs Product Portfolios and Specifications
Table 135. Teva Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Teva Main Business
Table 137. Teva Latest Developments
Table 138. Sun Pharmaceutical Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Sun Pharmaceutical Anti-itch Drugs Product Portfolios and Specifications
Table 140. Sun Pharmaceutical Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Sun Pharmaceutical Main Business
Table 142. Sun Pharmaceutical Latest Developments
Table 143. Perrigo Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. Perrigo Anti-itch Drugs Product Portfolios and Specifications
Table 145. Perrigo Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Perrigo Main Business
Table 147. Perrigo Latest Developments
List of Figures
Figure 1. Picture of Anti-itch Drugs
Figure 2. Anti-itch Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-itch Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Anti-itch Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Anti-itch Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Single Preparation
Figure 10. Product Picture of Compound Ointment
Figure 11. Global Anti-itch Drugs Sales Market Share by Type in 2022
Figure 12. Global Anti-itch Drugs Revenue Market Share by Type (2018-2023)
Figure 13. Anti-itch Drugs Consumed in Hospital
Figure 14. Global Anti-itch Drugs Market: Hospital (2018-2023) & (K Units)
Figure 15. Anti-itch Drugs Consumed in Pharmacy
Figure 16. Global Anti-itch Drugs Market: Pharmacy (2018-2023) & (K Units)
Figure 17. Anti-itch Drugs Consumed in Other
Figure 18. Global Anti-itch Drugs Market: Other (2018-2023) & (K Units)
Figure 19. Global Anti-itch Drugs Sales Market Share by Application (2022)
Figure 20. Global Anti-itch Drugs Revenue Market Share by Application in 2022
Figure 21. Anti-itch Drugs Sales Market by Company in 2022 (K Units)
Figure 22. Global Anti-itch Drugs Sales Market Share by Company in 2022
Figure 23. Anti-itch Drugs Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Anti-itch Drugs Revenue Market Share by Company in 2022
Figure 25. Global Anti-itch Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Anti-itch Drugs Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Anti-itch Drugs Sales 2018-2023 (K Units)
Figure 28. Americas Anti-itch Drugs Revenue 2018-2023 ($ Millions)
Figure 29. APAC Anti-itch Drugs Sales 2018-2023 (K Units)
Figure 30. APAC Anti-itch Drugs Revenue 2018-2023 ($ Millions)
Figure 31. Europe Anti-itch Drugs Sales 2018-2023 (K Units)
Figure 32. Europe Anti-itch Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Anti-itch Drugs Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Anti-itch Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Americas Anti-itch Drugs Sales Market Share by Country in 2022
Figure 36. Americas Anti-itch Drugs Revenue Market Share by Country in 2022
Figure 37. Americas Anti-itch Drugs Sales Market Share by Type (2018-2023)
Figure 38. Americas Anti-itch Drugs Sales Market Share by Application (2018-2023)
Figure 39. United States Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Anti-itch Drugs Sales Market Share by Region in 2022
Figure 44. APAC Anti-itch Drugs Revenue Market Share by Regions in 2022
Figure 45. APAC Anti-itch Drugs Sales Market Share by Type (2018-2023)
Figure 46. APAC Anti-itch Drugs Sales Market Share by Application (2018-2023)
Figure 47. China Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Anti-itch Drugs Sales Market Share by Country in 2022
Figure 55. Europe Anti-itch Drugs Revenue Market Share by Country in 2022
Figure 56. Europe Anti-itch Drugs Sales Market Share by Type (2018-2023)
Figure 57. Europe Anti-itch Drugs Sales Market Share by Application (2018-2023)
Figure 58. Germany Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Anti-itch Drugs Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Anti-itch Drugs Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Anti-itch Drugs Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Anti-itch Drugs Sales Market Share by Application (2018-2023)
Figure 67. Egypt Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Anti-itch Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Anti-itch Drugs in 2022
Figure 73. Manufacturing Process Analysis of Anti-itch Drugs
Figure 74. Industry Chain Structure of Anti-itch Drugs
Figure 75. Channels of Distribution
Figure 76. Global Anti-itch Drugs Sales Market Forecast by Region (2024-2029)
Figure 77. Global Anti-itch Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Anti-itch Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Anti-itch Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Anti-itch Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Anti-itch Drugs Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のかゆみ止め薬市場予測 2023年-2029年] (コード：LP23DC00448)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のかゆみ止め薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の子供用かゆみ止めクリーム市場予測 2023年-2029年
  • 世界の整形外科非ステロイド性抗炎症薬（NSAID）市場予測 2023年-2029年
  • 世界の経口抗アレルギー薬市場予測 2023年-2029年
  • 世界の全身性抗感染症薬市場予測 2023年-2029年
  • 世界のOTC局所用かゆみ止め市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆